View in EDS

A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care.

Saved in:
Bibliographic Details
Title: A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care.
Authors: Parramon-Teixido CJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain., Rodríguez-Pombo L; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain., Basit AW; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK.; FABRX Ltd, Henwood House, Henwood, Ashford, Kent, TN24 8DH, UK.; FABRX Artificial Inteligente, Calle Enrique Vidal Abascal 7 Bajo, Santiago de Compostela, CP, 15702, Spain., Worsley A; FABRX Ltd, Henwood House, Henwood, Ashford, Kent, TN24 8DH, UK.; FABRX Artificial Inteligente, Calle Enrique Vidal Abascal 7 Bajo, Santiago de Compostela, CP, 15702, Spain., Cañete-Ramírez C; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Alvarez-Lorenzo C; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain. carmen.alvarez.lorenzo@usc.es., Cabañas-Poy MJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. mjosep.cabanas@vallhebron.cat., Goyanes A; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain. a.goyanes@ucl.ac.uk.; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK. a.goyanes@ucl.ac.uk.; FABRX Ltd, Henwood House, Henwood, Ashford, Kent, TN24 8DH, UK. a.goyanes@ucl.ac.uk.; FABRX Artificial Inteligente, Calle Enrique Vidal Abascal 7 Bajo, Santiago de Compostela, CP, 15702, Spain. a.goyanes@ucl.ac.uk.
Source: Drug delivery and translational research [Drug Deliv Transl Res] 2025 Sep; Vol. 15 (9), pp. 3078-3097. Date of Electronic Publication: 2025 May 09.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2190-3948
DOI:10.1007/s13346-025-01868-y